This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Oxford BioTherapeutics

Drug Names(s): MEN1309

Description: OX002 is an antibody-drug conjugate (ADC) with an undisclosed mechanism of action. The ADC incorporates a fully human antibody generated by Amgen and ImmunoGen’s proprietary toxin technology.

OX002 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug